August 2018
Cycloadditions to Norbornadiene Derivatives
1923
À1
FTIR (cm ): 3060, 3030 (aromatic, C─H), 2971–2848
(
Ethyl (3aS*,4R*,4aS*,5R*,5aS*,6S*,6aS*)-3-(4-nitrophenyl)-
a,4a,5,5a,6,6a-hexahydro-4H-4,6-methanocyclopropa[4,5]
benzo[1,2-d]isoxazole-5-carboxylate (12c). Colorless crystals
1
3
Aliph., C─H), 1724 (C═O), 1590 (ÀC═N); H-NMR
(
300 MHz, CDCl ): δ = 7.74–7.68 (m, aromatic, 2H),
3
(
(
(
77 mg, 30%); mp 187–189°C; R = 0.31, ether/n-hexane
7
1
1
1
.42–7.38 (m, aromatic, 3H), 4.85 (bd, J = 8.3 Hz, OCH,
H), 4.16–4.06 (m, OCH , 2H), 3.74 (dd, J = 8.3, 1,5 Hz,
H), 2.94 (bs, bridgeahead, 1H), 2.85 (bs, bridgeahead,
H), 1.71 (t, J = 7.7 Hz, cyclopropane, 1H), 1.41–1.34 (m,
cyclopropane, 1H), 1.40–1.34 (m, cyclopropane, 1H), 1.32
bt, J = 7.1 Hz, CH , 3H), 1.27–1.08 (m, 2H), 0.70.71 (m,
H); C-NMR (75 MHz, CDCl ): δ = 174.45 (CO), 156.1
C), 130.2 (C), 129.2 (CH), 129.0 (CH), 127.0 (CH), 88.6
f
À1
1:10); FTIR (cm ): 3079–3028 (aromatic, C─H), 1722
2
1
C═O), 1600 (ÀC═N); H-NMR (300 MHz, CDCl3):
δ = 8.28–8.21 (m, aromatic, 2H), 7.90–7.82- (m, aromatic,
2
H), 4.94 (bd, J = 8.3 Hz, OCH, 1H), 4.15–4.05 (m,
OCH , 2H), 3.79 (bd, J = 8.3 Hz, 1H), 2.86 (bs,
(
1
2
3
13
bridgeahead, 1H), 2.68 (bs, bridgeahead, 1H), 2.00–1.95
m, cyclopropane, 1H), 1.65–1.58 (m, cyclopropane, 1H),
3
(
1
(
(
.42–1.37 (m, cyclopropane, 1H), 1.28–1.20 (m, CH3,
OCH), 61.3, 59.1, 43.4, 40.0, 25.6, 23.3, 22.6, 18.4, 14.3;
HRMS (APCI–Tof) calcd for [C H NO + H] :
m/z = 298.1443; found: 298.1426.
+
3H), 1.02 (bd, J = 12.0 Hz, A part of AB system, bridge,
H), 0.94 (bd, J = 12.0 Hz, B part of AB system, bridge,
19
21
4
1
1
3
Ethyl (3aS*,4R*,4aS*,5R*,5aS*,6S*,6aS*)-3-(4-methoxyphenyl)-
a,4a,5,5a,6,6a-hexahydro-4H-4,6-methanocyclopropa[4,5]benzo[1,2-
d]isoxazole-5-carboxylate (12b).
1H); C-NMR (75 MHz, CDCl
(C), 148.5 (C), 135.4 (C), 127.6 (CH), 124.3 (CH), 89.3
OCH), 61.1, 57.7, 43.1, 39.6, 25.9, 22.8, 21.8, 20.5,
3
): δ = 172.6 (CO), 154.8
3
Colorless crystals (73 mg,
5%); mp 173–175°C; R = 0.36, ether/n-hexane (1:10); FTIR
(
+
2
(
f
14.45; HRMS (APCI–Tof) calcd for [C18
H18NO + H] :
5
À1
cm ): 3079–3021 (aromatic, C-H), 1717 (C═O), 1607
m/z = 343.1294; found: 343.1278.
1
(
ÀC═N); H-NMR (300 MHz, CDCl ): δ = 7.63 (bd,
Ethyl (3aS*,4R*,4aS*,5S*,5aS*,6S*,6aS*)-3-(4-nitrophenyl)-
3a,4a,5,5a,6,6a-hexahydro-4H-4,6-methanocyclopropa[4,5]
benzo[1,2-d]isoxazole-5-carboxylate (13c). Colorless crystals
3
J = 9.0 Hz, A part of AB system, aromatic, 1H), 6.91 (bd,
J = 9.0 Hz, B part of AB system, aromatic, 1H), 4.83 (bd,
(
(
(
16 mg, 23%); mp 180–182°C; R = 0.28, ether/n-hexane
J = 8.3 Hz, OCH, 1H), 4.11 (bq, J = 6,9 Hz, OCH , 2H),
.83.(s, OMe, 3H) 3.76 (bd, J = 8.3 Hz, 1H), 2.81 (bs,
bridgeahead, 1H), 2.68 (bs, bridgeahead, 1H), 1.95 (bt,
f
2
À1
1:10); FTIR (cm ): 3122, 3073 (aromatic, C─H), 1713
C═O); H-NMR (300 MHz, CDCl ): δ = 8.28–8.22 (m,
3
1
3
aromatic, 2H), 7.90–7.84- (m, aromatic, 2H), 4.95–4.91
m, OCH, 1H), 4.16–4.08 (m, OCH , 2H), 3.74 (bd,
J = 2.4 Hz, cyclopropane, 1H), 1.62–1.55 (m, cyclopropane,
(
1H), 1.41–1.33 (m, cyclopropane, 1H), 1.25 (bt, J = 6.9 Hz,
2
J = 8.4 Hz, 1H), 2.99 (bs, bridgeahead, 1H), 2.83 (bs,
bridgeahead, 1H), 1.74 (bt, J = 7.2 Hz, cyclopropane, 1H),
1.42–1.36 (m, cyclopropane, 1H), 1.24–1.15 (m,
CH , 3H), 1.07 (bd, J = 12.0 Hz, A part of AB system,
3
bridge, 1H), 0.88 (bd, J = 12.0 Hz, B part of AB system,
13
bridge, 1H); C-NMR (75 MHz, CDCl ): δ = 172.9 (CO),
3
161.1 (C), 155.6 (C), 128.5 (CH), 121.7 (C), 114.4 (CH), 87.8
cyclopropane, 1H), 1.24 (bt, J = 7.1 Hz, CH , 3H), 1.05
3
(
1
OCH), 61.0, 58.7, 55.6, 43.17, 39.6, 26.2, 22.7, 22.1, 20.6,
(bd, J = 13.2 Hz, A part of AB system, bridge, 1H), 0.81
(bd, J = 12.0 Hz, B part of AB system, bridge, 1H); C-
+
13
4.5; HRMS (APCI–Tof) calcd for [C H NO + H] : m/
19
21
4
z = 328.1549; found: 328.1534.
NMR (75 MHz, CDCl ): δ = 171.2 (CO), 154.9 (C),
3
Ethyl (3aS*,4R*,4aS*,5S*,5aS*,6S*,6aS*)-3-(4-methoxyphenyl)-
a,4a,5,5a,6,6a-hexahydro-4H-4,6-methanocyclopropa[4,5]
benzo[1,2-d]isoxazole-5-carboxylate (13b).
1
48.5 (C), 135.4 (C), 127.6 (CH), 124.3 (CH), 89.8
3
(OCH), 61.4, 58.4, 43.3, 40.0, 25.6, 23.3, 22.5, 18.3, 14.3;
Colorless crystals
+
HRMS (APCI–Tof) calcd for [C H NO + H] : m/
z = 343.1294; found: 343.1291.
18
18
5
(
15 mg, 21%); mp 114–116°C; R = 0.17, ether/n-hexane
f
À1
(1:10); FTIR (cm ): 3082–3030 (aromatic, C─H), 1728
1
Cycloaddition reactions of mixtures of the products 9 and
0 (182 mg), with tetrazine.
(
C═O), 1606 (ÀC═N); H-NMR (300 MHz, CDCl3):
δ = 7.55 (bd, J = 9.0 Hz, A part of AB system,
aromatic, 1H), 6.90 (bd, J = 9.0 Hz, B part of AB
system, aromatic, 1H), 4.80 (bd, J = 7.8 Hz, OCH, 1H),
1
(
A mixture of products 9
140 mg, 0.79 mmol) and 10 (38 mg, 0.21 mmol) and
,6-di (2-pyridyl)-s-tetrazine (0.23 g, 1.0 mmol) in CHCl3
5 mL) was refluxed overnight, and then solvent was
3
(
4
.17–4.06 (m, OCH , 2H), 3.83.(s, OMe, 3H) 3.72 (bd,
2
removed under vacuum. Purification of resulting adducts
on silica gel column (48 g) with ether/hexane (1/10)
elution gave 19 (52 mg, 17%) and 20 (12 mg, 15%).
Exo-ethyl (5R,5aS,6aS,7S)-1,4-di (pyridin-2-yl)-5a,6,6a,7-
tetrahydro-5H-5,7-methanocyclopropa
carboxylate (19).
J = 7.8 Hz, 1H), 2.93 (bs, bridgeahead, 1H), 2.83 (bs,
bridgeahead, 1H), 1.73–1.66 (m, cyclopropane, 1H), 1.39–
1
.33 (m, cyclopropane, 1H), 1.23 (bt, J = 7.2 Hz, CH3,
H), 1.22–1.08 (m, 2H) 1.23 (bt, J = 12.0 Hz, A part of
AB system, bridge, 1H), 0.74 (bd, J = 12.2 Hz, B part
3
[g]phthalazine-6-
13
Mp 200–202°C; R = 0.21, ethyl
f
of AB system, bridge, 1H); C-NMR (75 MHz, CDCl3):
À1
acetate/n-hexane (1:10); FTIR (cm ): 3063, 3053
δ = 171.5 (CO), 161.1 (C), 155.7 (C), 128.5 (CH), 121.7
1
(aromatic, C─H), 1708 (C═O); H-NMR (300 MHz,
(C), 114.4 (CH), 88.2 (OCH), 61.3, 59.4, 55.6, 43.3,
CDCl ): δ = 8.76 (bd, J = 3.7 Hz, aromatic, 2H), 8.61
(bd, J = 8.0 Hz, aromatic, 2H), 7.97–7.85 (m, aromatic,
2H), 7.41–7.34 (m, aromatic, 2H), 4.64 (bs, bridgeahead,
4
0.0, 25.6, 23.2, 22.6, 18.4, 14.3; HRMS (APCI–Tof)
3
+
calcd for [C H NO + H] : m/z = 328.1549; found:
1
9
21
4
328.1536.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet